These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 15276470)

  • 1. Interference of antihypertrophic molecules and signaling pathways with the Ca2+-calcineurin-NFAT cascade in cardiac myocytes.
    Fiedler B; Wollert KC
    Cardiovasc Res; 2004 Aug; 63(3):450-7. PubMed ID: 15276470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcineurin-NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs.
    Molkentin JD
    Cardiovasc Res; 2004 Aug; 63(3):467-75. PubMed ID: 15276472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct and indirect interactions between calcineurin-NFAT and MEK1-extracellular signal-regulated kinase 1/2 signaling pathways regulate cardiac gene expression and cellular growth.
    Sanna B; Bueno OF; Dai YS; Wilkins BJ; Molkentin JD
    Mol Cell Biol; 2005 Feb; 25(3):865-78. PubMed ID: 15657416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of calcineurin-NFAT hypertrophy signaling by cGMP-dependent protein kinase type I in cardiac myocytes.
    Fiedler B; Lohmann SM; Smolenski A; Linnemuller S; Pieske B; Schroder F; Molkentin JD; Drexler H; Wollert KC
    Proc Natl Acad Sci U S A; 2002 Aug; 99(17):11363-8. PubMed ID: 12177418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heme oxygenase-1 inhibition of MAP kinases, calcineurin/NFAT signaling, and hypertrophy in cardiac myocytes.
    Tongers J; Fiedler B; König D; Kempf T; Klein G; Heineke J; Kraft T; Gambaryan S; Lohmann SM; Drexler H; Wollert KC
    Cardiovasc Res; 2004 Aug; 63(3):545-52. PubMed ID: 15276480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium-calcineurin signaling in the regulation of cardiac hypertrophy.
    Wilkins BJ; Molkentin JD
    Biochem Biophys Res Commun; 2004 Oct; 322(4):1178-91. PubMed ID: 15336966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NFAT transcription factors are critical survival factors that inhibit cardiomyocyte apoptosis during phenylephrine stimulation in vitro.
    Pu WT; Ma Q; Izumo S
    Circ Res; 2003 Apr; 92(7):725-31. PubMed ID: 12663489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of Na+/H+ exchanger 1 is sufficient to generate Ca2+ signals that induce cardiac hypertrophy and heart failure.
    Nakamura TY; Iwata Y; Arai Y; Komamura K; Wakabayashi S
    Circ Res; 2008 Oct; 103(8):891-9. PubMed ID: 18776042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of TRPC6 channel activity contributes to the antihypertrophic effects of natriuretic peptides-guanylyl cyclase-A signaling in the heart.
    Kinoshita H; Kuwahara K; Nishida M; Jian Z; Rong X; Kiyonaka S; Kuwabara Y; Kurose H; Inoue R; Mori Y; Li Y; Nakagawa Y; Usami S; Fujiwara M; Yamada Y; Minami T; Ueshima K; Nakao K
    Circ Res; 2010 Jun; 106(12):1849-60. PubMed ID: 20448219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased regulatory activity of the calcineurin/NFAT pathway in human heart failure.
    Diedrichs H; Chi M; Boelck B; Mehlhorn U; Schwinger RH
    Eur J Heart Fail; 2004 Jan; 6(1):3-9. PubMed ID: 15012912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced Ca2+ channel currents in cardiac hypertrophy induced by activation of calcineurin-dependent pathway.
    Yatani A; Honda R; Tymitz KM; Lalli MJ; Molkentin JD
    J Mol Cell Cardiol; 2001 Feb; 33(2):249-59. PubMed ID: 11162130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of nerve growth factor in the heart: the role of the calcineurin-NFAT pathway.
    Rana OR; Saygili E; Meyer C; Gemein C; Krüttgen A; Andrzejewski MG; Ludwig A; Schotten U; Schwinger RH; Weber C; Weis J; Mischke K; Rassaf T; Kelm M; Schauerte P
    J Mol Cell Cardiol; 2009 Apr; 46(4):568-78. PubMed ID: 19150448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the Ca(2+)/calcineurin/NFAT2 pathway controls smooth muscle cell differentiation.
    Larrieu D; Thiébaud P; Duplàa C; Sibon I; Thézé N; Lamazière JM
    Exp Cell Res; 2005 Oct; 310(1):166-75. PubMed ID: 16129432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms underlying rate-dependent remodeling of transient outward potassium current in canine ventricular myocytes.
    Xiao L; Coutu P; Villeneuve LR; Tadevosyan A; Maguy A; Le Bouter S; Allen BG; Nattel S
    Circ Res; 2008 Sep; 103(7):733-42. PubMed ID: 18723449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcineurin activation is not necessary for Doxorubicin-induced hypertrophy in H9c2 embryonic rat cardiac cells: involvement of the phosphoinositide 3-kinase-Akt pathway.
    Merten KE; Jiang Y; Feng W; Kang YJ
    J Pharmacol Exp Ther; 2006 Nov; 319(2):934-40. PubMed ID: 16926266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphatidylinositol 3-kinase and calcium-activated transcription pathways are required for VLDL-induced smooth muscle cell proliferation.
    Lipskaia L; Pourci ML; Deloménie C; Combettes L; Goudounèche D; Paul JL; Capiod T; Lompré AM
    Circ Res; 2003 May; 92(10):1115-22. PubMed ID: 12730091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leptin-induced cardiomyocyte hypertrophy reveals both calcium-dependent and calcium-independent/RhoA-dependent calcineurin activation and NFAT nuclear translocation.
    Rajapurohitam V; Izaddoustdar F; Martinez-Abundis E; Karmazyn M
    Cell Signal; 2012 Dec; 24(12):2283-90. PubMed ID: 22917533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcineurin regulates NFAT-dependent iNOS expression and protection of cardiomyocytes: co-operation with Src tyrosine kinase.
    Obasanjo-Blackshire K; Mesquita R; Jabr RI; Molkentin JD; Hart SL; Marber MS; Xia Y; Heads RJ
    Cardiovasc Res; 2006 Sep; 71(4):672-83. PubMed ID: 16828070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted inhibition of p38 MAPK promotes hypertrophic cardiomyopathy through upregulation of calcineurin-NFAT signaling.
    Braz JC; Bueno OF; Liang Q; Wilkins BJ; Dai YS; Parsons S; Braunwart J; Glascock BJ; Klevitsky R; Kimball TF; Hewett TE; Molkentin JD
    J Clin Invest; 2003 May; 111(10):1475-86. PubMed ID: 12750397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-type Ca2+ channel blockers prevent cardiac cell hypertrophy through an inhibition of calcineurin-NFAT3 activation as well as L-type Ca2+ channel blockers.
    Horiba M; Muto T; Ueda N; Opthof T; Miwa K; Hojo M; Lee JK; Kamiya K; Kodama I; Yasui K
    Life Sci; 2008 Mar; 82(11-12):554-60. PubMed ID: 18275974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.